These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 19116626)

  • 1. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
    Conn PJ; Christopoulos A; Lindsley CW
    Nat Rev Drug Discov; 2009 Jan; 8(1):41-54. PubMed ID: 19116626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of allosteric modulators of GPCRs for treatment of CNS disorders.
    Nickols HH; Conn PJ
    Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.
    Conn PJ; Lindsley CW; Meiler J; Niswender CM
    Nat Rev Drug Discov; 2014 Sep; 13(9):692-708. PubMed ID: 25176435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology.
    Wood MR; Hopkins CR; Brogan JT; Conn PJ; Lindsley CW
    Biochemistry; 2011 Apr; 50(13):2403-10. PubMed ID: 21341760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
    Reinecke BA; Wang H; Zhang Y
    Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
    Müller CE; Schiedel AC; Baqi Y
    Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
    Digby GJ; Shirey JK; Conn PJ
    Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders.
    Engers DW; Lindsley CW
    Drug Discov Today Technol; 2013; 10(2):e269-76. PubMed ID: 24050278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
    Lütjens R; Rocher JP
    Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain.
    Felder CC
    Adv Pharmacol; 2019; 86():1-20. PubMed ID: 31378249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
    Lindsley CW; Emmitte KA; Hopkins CR; Bridges TM; Gregory KJ; Niswender CM; Conn PJ
    Chem Rev; 2016 Jun; 116(11):6707-41. PubMed ID: 26882314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.